Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-20-004805
Filing Date
2020-02-25
Accepted
2020-02-25 16:04:10
Documents
1
Period of Report
2020-02-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4193
  Complete submission text file 0001567619-20-004805.txt   5660
Mailing Address C/O XENCOR, INC. 111 WEST LEMON AVENUE MONROVIA CA 91016
Business Address
Hata Yujiro S (Reporting) CIK: 0001649119 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38915 | Film No.: 20650579

Mailing Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Issuer) CIK: 0001676725 (see all company filings)

EIN.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations